This week in gene and cell therapy - 5 April 2019

Gene and cell therapy headlines 1 - 5 April

New protein for gene editing may improve disease treatment, sustainable manufacturing

Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia